Masimo Radical-7 Monitor a Useful Adjuvant During Major Spine Surgery
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01221961|
Recruitment Status : Terminated (We completed the 62% of the cases, enough data to get a conclusion of the study.)
First Posted : October 18, 2010
Last Update Posted : November 15, 2013
|Condition or disease||Intervention/treatment|
|Major Spine Surgery Procedure||Device: Masimo Radical-7|
|Study Type :||Observational|
|Actual Enrollment :||62 participants|
|Official Title:||A Study to Determine the Agreement Between Masimo Monitor and Standard of Care|
|Study Start Date :||October 2010|
|Actual Primary Completion Date :||April 2013|
|Actual Study Completion Date :||April 2013|
Device: Masimo Radical-7
- Hemoglobin value [ Time Frame: 0-8 hours ]During the time surgery last.
- Blood transfusion [ Time Frame: 0-8 hours ]During the time surgery last.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01221961
|United States, California|
|Cedars Sinai Medical center|
|Los Angeles, California, United States, 90048|
|Principal Investigator:||Ronald H Wender, MD||Cedars-Sinai Medical Center|